Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) saw a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 100 shares, a decline of 66.7% from the February 13th total of 300 shares. Currently, 0.0% of the company's shares are sold short. Based on an average daily trading volume, of 17,600 shares, the days-to-cover ratio is currently 0.0 days.
Elekta AB (publ) Trading Down 0.1 %
EKTAY traded down $0.00 during trading on Thursday, hitting $5.55. 4,362 shares of the company's stock were exchanged, compared to its average volume of 9,286. The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60. The firm has a market cap of $2.13 billion, a P/E ratio of 22.19 and a beta of 1.25. The stock has a 50 day moving average price of $5.75 and a 200 day moving average price of $6.01. Elekta AB has a 1 year low of $5.25 and a 1 year high of $8.24.
Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) last posted its quarterly earnings results on Friday, February 21st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). The company had revenue of $416.86 million during the quarter, compared to analyst estimates of $435.89 million. Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. As a group, analysts expect that Elekta AB will post 0.36 EPS for the current fiscal year.
Elekta AB (publ) Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Thursday, March 27th. Investors of record on Friday, March 7th will be issued a $0.1072 dividend. The ex-dividend date of this dividend is Friday, March 7th. Elekta AB (publ)'s dividend payout ratio is currently 40.00%.
Wall Street Analysts Forecast Growth
Separately, Sanford C. Bernstein upgraded Elekta AB (publ) from a "strong sell" rating to a "hold" rating in a report on Wednesday, January 29th.
View Our Latest Stock Report on Elekta AB (publ)
Elekta AB (publ) Company Profile
(
Get Free Report)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Elekta AB (publ), you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta AB (publ) wasn't on the list.
While Elekta AB (publ) currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
